These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22803583)

  • 1. Ocular toxicity from systemically administered xenobiotics.
    Gokulgandhi MR; Vadlapudi AD; Mitra AK
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1277-91. PubMed ID: 22803583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular toxicity assessment from systemically administered xenobiotics: considerations in drug development.
    Brock WJ; Somps CJ; Torti V; Render JA; Jamison J; Rivera MI
    Int J Toxicol; 2013; 32(3):171-88. PubMed ID: 23616147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular complications of systemic medications.
    Blomquist PH
    Am J Med Sci; 2011 Jul; 342(1):62-9. PubMed ID: 21139494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oculotoxicities of systemically administered drugs.
    Koneru PB; Lien EJ; Koda RT
    J Ocul Pharmacol; 1986; 2(4):385-404. PubMed ID: 3332287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.
    Kadam RS; Jadhav G; Ogidigben M; Kompella UB
    Drug Metab Dispos; 2011 Sep; 39(9):1529-37. PubMed ID: 21673129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic determinants of chronic visual pathway changes after methanol - induced optic neuropathy: four-year follow-up study.
    Nurieva O; Hubacek JA; Urban P; Hlusicka J; Diblik P; Kuthan P; Sklenka P; Meliska M; Bydzovsky J; Heissigerova J; Kotikova K; Navratil T; Komarc M; Seidl Z; Vaneckova M; Vojtova L; Zakharov S
    Clin Toxicol (Phila); 2019 Jun; 57(6):387-397. PubMed ID: 30451020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of the ocular safety of excipient maleic acid following intravitreal injection in rabbits.
    Aguirre SA; Collette W; Gukasyan HJ; Huang W
    Toxicol Pathol; 2012 Jul; 40(5):797-806. PubMed ID: 22552388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bunazosin, a selective alpha1-adrenoceptor antagonist, as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.
    Hara H; Ichikawa M; Oku H; Shimazawa M; Araie M
    Cardiovasc Drug Rev; 2005; 23(1):43-56. PubMed ID: 15867947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced ocular disorders.
    Li J; Tripathi RC; Tripathi BJ
    Drug Saf; 2008; 31(2):127-41. PubMed ID: 18217789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics.
    Mannermaa E; Vellonen KS; Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1136-63. PubMed ID: 17081648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganglion Cell Layer and Inner Plexiform Layer as Predictors of Vision Recovery in Ethambutol-Induced Optic Neuropathy: A Longitudinal OCT Analysis.
    Lee JY; Choi JH; Park KA; Oh SY
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):2104-2109. PubMed ID: 29677374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular side effects of drugs].
    Müller-Breitenkamp U; Hockwin O
    Laryngorhinootologie; 1992 Apr; 71(4):226-8. PubMed ID: 1575856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is silicone oil optic neuropathy caused by high intraocular pressure alone? A semi-biological model.
    Knecht P; Groscurth P; Ziegler U; Laeng HR; Jaggi GP; Killer HE
    Br J Ophthalmol; 2007 Oct; 91(10):1293-5. PubMed ID: 17475700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular adverse effects of common psychotropic agents: a review.
    Richa S; Yazbek JC
    CNS Drugs; 2010 Jun; 24(6):501-26. PubMed ID: 20443647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular toxicology.
    Novack GD
    Curr Opin Ophthalmol; 1997 Dec; 8(6):88-92. PubMed ID: 10176110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a rodent model of methanol-induced retinal and optic nerve toxicity.
    Eells JT; Henry MM; Lewandowski MF; Seme MT; Murray TG
    Neurotoxicology; 2000 Jun; 21(3):321-30. PubMed ID: 10894122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of ocular toxicity of ethambutol: study of zincaemia and chromatic analysis (author's transl)].
    Delacoux E; Moreau Y; Godefroy A; Evstigneeff T
    J Fr Ophtalmol; 1978 Mar; 1(3):191-6. PubMed ID: 659802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.
    Hara H; Toriu N; Shimazawa M
    Cardiovasc Drug Rev; 2004; 22(3):199-214. PubMed ID: 15492768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic drugs, steroids, and vision.
    Grant WM
    Sight Sav Rev; 1970; 40(1):19-29. PubMed ID: 5429399
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimally invasive microneedles for ocular drug delivery.
    Thakur Singh RR; Tekko I; McAvoy K; McMillan H; Jones D; Donnelly RF
    Expert Opin Drug Deliv; 2017 Apr; 14(4):525-537. PubMed ID: 27485251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.